Shim, Injeong http://orcid.org/0000-0002-1001-0945
Kuwahara, Hiroyuki
Chen, NingNing http://orcid.org/0000-0003-4340-7268
Hashem, Mais O.
AlAbdi, Lama http://orcid.org/0000-0001-8177-4048
Abouelhoda, Mohamed
Won, Hong-Hee
Natarajan, Pradeep http://orcid.org/0000-0001-8402-7435
Ellinor, Patrick T. http://orcid.org/0000-0002-2067-0533
Khera, Amit V.
Gao, Xin http://orcid.org/0000-0002-7108-3574
Alkuraya, Fowzan S. http://orcid.org/0000-0003-4158-341X
Fahed, Akl C. http://orcid.org/0000-0002-4849-6389
Funding for this research was provided by:
U.S. Department of Health & Human Services | NIH | National Heart, Lung, and Blood Institute (1K08HL161448, R01HL164629)
U.S. Department of Health & Human Services | NIH | National Heart, Lung, and Blood Institute
Article History
Received: 13 January 2023
Accepted: 25 September 2023
First Online: 18 October 2023
Competing interests
: P.N. reports grant support from Amgen, Apple, AstraZeneca, Boston Scientific, and Novartis, personal fees from Allelica, Apple, AstraZeneca, Blackstone Life Sciences, Foresite Labs, Genentech/Roche, and Novartis, is a scientific advisory board member of Esperion Therapeutics, geneXwell, and TenSixteen Bio, is a co-founder of TenSixteen Bio, and spousal employment at Vertex, all unrelated to the present work. P.T.E. has received sponsored research support from Bayer AG and IBM Health, and he has served on advisory boards or consulted for Bayer AG, MyoKardia and Novartis. A.V.K. is an employee of Verve Therapeutics; has served as a scientific advisor to Amgen, Novartis, Silence Therapeutics, Korro Bio, Veritas International, Color Health, Third Rock Ventures, Illumina, Ambry, and Foresite Labs; holds equity in Verve Therapeutics, Color Health, and Foresite Labs; and is listed as a co-inventor on patent applications related to assessment and mitigation of risk associated with perturbations in body fat distribution. A.C.F. reports grant support from Abbott Laboratories and is co-founder of Goodpath. The remaining authors declare no competing interests.